4572 · Carna Biosciences, Inc. · Financials
Market Cap
6.66B JPY
Shares
21.15M
Volume · Nov 13
437.9K
Avg daily vol (3M)
193.71K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
579.06M
-9%
FY2025
Net Income
-2.17B
+0.3%
FY2025
Gross Margin
67.03%
-6.2pp
FY2025
Operating Margin
-358.34%
-32pp
FY2025
Operating Cash Flow
-2.16B
-57.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| JPY | 579.06M | 636.24M | 1.63B | 1.39B | 2.02B |
| JPY | 190.91M | 170.54M | 175.29M | 171.55M | 135.39M |
| JPY | 388.15M | 465.69M | 1.45B | 1.22B | 1.88B |
| JPY | -2.07B | -2.08B | -1.12B | -1.27B | -531.14M |
| JPY | -2.17B | -2.17B | -1.13B | -1.32B | -532.5M |
| JPY | 1.85M | 4.6M | 22.05M | 26.14M | 1.98M |
| JPY | -2.17B | -2.18B | -1.15B | -1.35B | -534.47M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.